CD4 and neoplasm: However, in the later phase, tumors can evade the immune defenses and progress by creating an immunosuppressive TME containing M2 tumor-associated macrophages (TAMs), CD4+ Th2 cells, and, especially, regulatory T cells (Tregs) [25].